Citation: N. Kleinkauf et Ac. Rodloff, Interpretive criteria of ceftibuten disk diffusion susceptibility tests according to the DIN 58 940 method, CL MICRO IN, 7(6), 2001, pp. 326-330
Authors:
Ackermann, G
Tang, YJ
Henderson, JP
Rodloff, AC
Silva, J
Cohen, SH
Citation: G. Ackermann et al., Electroporation of DNA sequences from the pathogenicity locus (PaLoc) of toxigenic Clostridium difficile into a non-toxigenic strain, MOL CELL PR, 15(5), 2001, pp. 301-306
Authors:
Ackermann, G
Tang, YJ
Jang, SS
Silva, J
Rodloff, AC
Cohen, SH
Citation: G. Ackermann et al., Isolation of Clostridium innocuum from cases of recurrent diarrhea in patients with prior Clostridium difficile associated diarrhea, DIAG MICR I, 40(3), 2001, pp. 103-106
Authors:
Ackermann, G
Tang, YJ
Rodloff, AC
Silva, J
Cohen, SH
Heisig, P
Citation: G. Ackermann et al., In vitro activity of sitafloxacin against Clostridium difficile - J Antimicrob Chemother 2001: 47: 722-724, J ANTIMICRO, 47(5), 2001, pp. 722-724
Authors:
Schaumann, R
Ponisch, W
Helbig, JH
Hegenbart, U
Ackermann, G
Hofmann, J
Niederwieser, D
Rodloff, AC
Citation: R. Schaumann et al., Pericarditis after allogeneic peripheral blood stem cell transplantation caused by Legionella pneumophila (non-serogroup 1), INFECTION, 29(1), 2001, pp. 51-53
Authors:
Ackermann, G
Tang, YJ
Kueper, R
Heisig, P
Rodloff, AC
Silva, J
Cohen, SH
Citation: G. Ackermann et al., Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA, ANTIM AG CH, 45(8), 2001, pp. 2348-2353
Authors:
Kleinkauf, N
Ackermann, G
Schaumann, R
Rodloff, AC
Citation: N. Kleinkauf et al., Comparative in vitro activities of gemifloxacin, other quinolones, and nonquinolone antimicrobials against obligately anaerobic bacteria, ANTIM AG CH, 45(6), 2001, pp. 1896-1899
Authors:
Spencker, FB
Haupt, S
Claros, MC
Walter, S
Lietz, T
Schille, R
Rodloff, AC
Citation: Fb. Spencker et al., Epidemiologic characterization of Pseudomonas aeruginosa in patients with cystic fibrosis, CL MICRO IN, 6(11), 2000, pp. 600-607
Authors:
Ackermann, G
Schaumann, R
Pless, B
Claros, MC
Goldstein, EJC
Rodloff, AC
Citation: G. Ackermann et al., Comparative activity of moxifloxacin in vitro against obligately anaerobicbacteria, EUR J CL M, 19(3), 2000, pp. 228-232
Authors:
Schaumann, R
Ackermann, G
Pless, B
Claros, MC
Goldstein, EJC
Rodloff, AC
Citation: R. Schaumann et al., In vitro activities of fourteen antimicrobial agents against obligately anaerobic bacteria, INT J ANT A, 16(3), 2000, pp. 225-232
Authors:
Ackermann, G
Schaumann, R
Pless, B
Claros, MC
Rodloff, AC
Citation: G. Ackermann et al., In vitro activity of telithromycin (HMR 3647) and seven other antimicrobial agents against anaerobic bacteria, J ANTIMICRO, 46(1), 2000, pp. 115-119
Authors:
Claros, MC
Claros, ZC
Tang, YJ
Cohen, SH
Silva, J
Goldstein, EJC
Rodloff, AC
Citation: Mc. Claros et al., Occurrence of Bacteroides fragilis enterotoxin gene-carrying strains in Germany and the United States, J CLIN MICR, 38(5), 2000, pp. 1996-1997
Authors:
Claros, MC
Papke, Y
Kleinkauf, N
Adler, D
Citron, DM
Hunt-Gerardo, S
Montag, T
Goldstein, EJC
Rodloff, AC
Citation: Mc. Claros et al., Characteristics of Fusobacterium ulcerans, a new and unusual species compared with Fusobacterium varium and Fusobacterium mortiferum, ANAEROBE, 5(3-4), 1999, pp. 137-140
Authors:
Schaumann, R
Ackermann, G
Pless, B
Claros, MC
Rodloff, AC
Citation: R. Schaumann et al., In vitro activities of gatifloxacin, two other quinolones, and five nonquinolone antimicrobials against obligately anaerobic bacteria, ANTIM AG CH, 43(11), 1999, pp. 2783-2786